{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:20:05Z","timestamp":1791944405842,"version":"4.3.4"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1093\/neuonc\/nop075","type":"journal-article","created":{"date-parts":[[2010,7,28]],"date-time":"2010-07-28T20:19:16Z","timestamp":1280348356000},"page":"664-678","source":"Crossref","is-referenced-by-count":76,"title":["Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses\u2020"],"prefix":"10.1093","volume":"12","author":[{"given":"Artemis P.","family":"Vogazianou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Magnus","family":"B\u00e4cklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danita M.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cordelia F.","family":"Langford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon G.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Peter","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,2,17]]},"reference":[{"key":"key\n\t\t\t\t20170508160334_NOP075C1","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/01.jnen.0000235122.98052.8f","article-title":"Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss","volume":"65","author":"Griffin","year":"2006","journal-title":"J Neuropathol Exp Neurol."},{"key":"key\n\t\t\t\t20170508160334_NOP075C2","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1158\/0008-5472.CAN-06-1796","article-title":"A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma","volume":"66","author":"Jenkins","year":"2006","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170508160334_NOP075C3","volume-title":"WHO Classification of Tumours of the Central Nervous System","author":"Louis","year":"2007","edition":"4th"},{"key":"key\n\t\t\t\t20170508160334_NOP075C4","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1200\/JCO.2005.04.3414","article-title":"Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402","volume":"24","author":"Cairncross","year":"2006","journal-title":"J Clin Oncol."},{"key":"key\n\t\t\t\t20170508160334_NOP075C5","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1200\/JCO.2005.04.6078","article-title":"Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial","volume":"24","author":"van den Bent","year":"2006","journal-title":"J Clin Oncol."},{"key":"key\n\t\t\t\t20170508160334_NOP075C6","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/sj.onc.1210848","article-title":"1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas","volume":"27","author":"Ichimura","year":"2008","journal-title":"Oncogene."},{"key":"key\n\t\t\t\t20170508160334_NOP075C7","first-page":"4100","article-title":"Transcript map of the 3.7-Mb D19S112\u2013D19S246 candidate tumor suppressor region on the long arm of chromosome 19","volume":"62","author":"Hartmann","year":"2002","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170508160334_NOP075C8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ana.20607","article-title":"Two types of chromosome 1p losses with opposite significance in gliomas","volume":"58","author":"Idbaih","year":"2005","journal-title":"Ann Neurol."},{"key":"key\n\t\t\t\t20170508160334_NOP075C9","first-page":"417","article-title":"Deregulation of the p14ARF\/MDM2\/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities","volume":"60","author":"Ichimura","year":"2000","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170508160334_NOP075C10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/(SICI)1098-2264(199805)22:1<9::AID-GCC2>3.0.CO;2-1","article-title":"Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades","volume":"22","author":"Ichimura","year":"1998","journal-title":"Genes Chromosomes Cancer."},{"key":"key\n\t\t\t\t20170508160334_NOP075C11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00005072-200606000-00003","article-title":"High-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive neuroectodermal tumors","volume":"65","author":"McCabe","year":"2006","journal-title":"J Neuropathol Exp Neurol."},{"key":"key\n\t\t\t\t20170508160334_NOP075C12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1215\/15228517-2007-002","article-title":"Survey of treatment recommendations for anaplastic oligodendroglioma","volume":"9","author":"Abrey","year":"2007","journal-title":"Neuro-Oncology."},{"key":"key\n\t\t\t\t20170508160334_NOP075C13","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/jnci\/90.19.1473","article-title":"Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas","volume":"90","author":"Cairncross","year":"1998","journal-title":"J Natl Cancer Inst."},{"key":"key\n\t\t\t\t20170508160334_NOP075C14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1200\/JCO.2000.18.3.636","article-title":"Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas","volume":"18","author":"Smith","year":"2000","journal-title":"J Clin Oncol."},{"key":"key\n\t\t\t\t20170508160334_NOP075C15","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1200\/JCO.2006.06.3891","article-title":"Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study","volume":"24","author":"Brandes","year":"2006","journal-title":"J Clin Oncol."},{"key":"key\n\t\t\t\t20170508160334_NOP075C16","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/ijc.23270","article-title":"BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas","volume":"122","author":"Idbaih","year":"2008","journal-title":"Int J Cancer."},{"key":"key\n\t\t\t\t20170508160334_NOP075C17","doi-asserted-by":"crossref","first-page":"6933","DOI":"10.1158\/1078-0432.CCR-07-0573","article-title":"Combined 1p\/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?","volume":"13","author":"Weller","year":"2007","journal-title":"Clin Cancer Res."},{"key":"key\n\t\t\t\t20170508160334_NOP075C18","first-page":"4151","article-title":"Short postoperative survival for glioblastoma patients with a dysfunctional Rb1 pathway in combination with no wild-type PTEN","volume":"9","author":"Backlund","year":"2003","journal-title":"Clin Cancer Res."},{"key":"key\n\t\t\t\t20170508160334_NOP075C19","first-page":"839","article-title":"Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis","volume":"7","author":"Ino","year":"2001","journal-title":"Clin Cancer Res."},{"key":"key\n\t\t\t\t20170508160334_NOP075C20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/nen.0b013e31815f65fb","article-title":"Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers","volume":"67","author":"Yip","year":"2008","journal-title":"J Neuropathol Exp Neurol."},{"key":"key\n\t\t\t\t20170508160334_NOP075C21","first-page":"4705","article-title":"Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene","volume":"6","author":"van Kuilenburg","year":"2000","journal-title":"Clin Cancer Res."},{"key":"key\n\t\t\t\t20170508160334_NOP075C22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01059957","article-title":"A phase II study of 5-fluorouracil plus folinic acid in malignant gliomas in adults","volume":"23","author":"Stewart","year":"1995","journal-title":"J Neurooncol."},{"key":"key\n\t\t\t\t20170508160334_NOP075C23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2006.02.004","article-title":"FRA1E common fragile site breaks map within a 370kilobase pair region and disrupt the dihydropyrimidine dehydrogenase gene (DPYD)","volume":"246","author":"Hormozian","year":"2007","journal-title":"Cancer Lett."},{"key":"key\n\t\t\t\t20170508160334_NOP075C24","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/00005072-199910000-00002","article-title":"Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors","volume":"58","author":"Husemann","year":"1999","journal-title":"J Neuropathol Exp Neurol."},{"key":"key\n\t\t\t\t20170508160334_NOP075C25","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1750-3639.1999.tb00545.x","article-title":"Homozygous deletions of the CDKN2C\/p18INK4C gene on the short arm of chromosome 1 in anaplastic oligodendrogliomas","volume":"9","author":"Pohl","year":"1999","journal-title":"Brain Pathol."},{"key":"key\n\t\t\t\t20170508160334_NOP075C26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2008.02.010","article-title":"Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development","volume":"13","author":"Wiedemeyer","year":"2008","journal-title":"Cancer Cell."},{"key":"key\n\t\t\t\t20170508160334_NOP075C27","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"McLendon","year":"2008","journal-title":"Nature."},{"key":"key\n\t\t\t\t20170508160334_NOP075C28","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1073\/pnas.0808816106","article-title":"Activated TNF-alpha\/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice","volume":"106","author":"Altomare","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"key\n\t\t\t\t20170508160334_NOP075C29","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00109-004-0565-9","article-title":"Pathology and molecular genetics of oligodendroglial tumors","volume":"82","author":"Hartmann","year":"2004","journal-title":"J Mol Med."},{"key":"key\n\t\t\t\t20170508160334_NOP075C30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1750-3639.2007.00083.x","article-title":"DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in Human Gliomas","volume":"17","author":"Kunitz","year":"2007","journal-title":"Brain Pathol."},{"key":"key\n\t\t\t\t20170508160334_NOP075C31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1101\/gad.1040003","article-title":"p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3","volume":"17","author":"Wolf","year":"2003","journal-title":"Genes Dev."},{"key":"key\n\t\t\t\t20170508160334_NOP075C32","first-page":"7600","article-title":"The contribution of genetic and epigenetic mechanisms to gene silencing in oligodendrogliomas","volume":"63","author":"Hong","year":"2003","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170508160334_NOP075C33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cancergencyto.2003.09.021","article-title":"Parental 19q loss and PEG3 expression in oligodendrogliomas","volume":"151","author":"Trouillard","year":"2004","journal-title":"Cancer Genet Cytogenet."},{"key":"key\n\t\t\t\t20170508160334_NOP075C34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature02399","article-title":"The DNA sequence and biology of human chromosome 19","volume":"428","author":"Grimwood","year":"2004","journal-title":"Nature."},{"key":"key\n\t\t\t\t20170508160334_NOP075C35","doi-asserted-by":"crossref","first-page":"11502","DOI":"10.1158\/0008-5472.CAN-06-2072","article-title":"Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities","volume":"66","author":"Maher","year":"2006","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170508160334_NOP075C36","doi-asserted-by":"crossref","first-page":"9428","DOI":"10.1158\/0008-5472.CAN-06-1691","article-title":"High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances","volume":"66","author":"Kotliarov","year":"2006","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170508160334_NOP075C37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/gcc.10111","article-title":"The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors","volume":"35","author":"Kolomietz","year":"2002","journal-title":"Genes Chromosomes Cancer."},{"key":"key\n\t\t\t\t20170508160334_NOP075C38","first-page":"184","article-title":"The new human tissue kallikrein gene family: structure, function, and association to disease","volume":"22","author":"Yousef","year":"2001","journal-title":"Endocr Rev."},{"key":"key\n\t\t\t\t20170508160334_NOP075C39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nri2056","article-title":"Siglecs and their roles in the immune system","volume":"7","author":"Crocker","year":"2007","journal-title":"Nat Rev Immunol."},{"key":"key\n\t\t\t\t20170508160334_NOP075C40","doi-asserted-by":"crossref","first-page":"18255","DOI":"10.1073\/pnas.0808756105","article-title":"A functional proteomics approach links the ubiquitin-related modifier Urm1 to a tRNA modification pathway","volume":"105","author":"Schlieker","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"key\n\t\t\t\t20170508160334_NOP075C41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0898-6568(01)00271-6","article-title":"The protein kinase B\/Akt signalling pathway in human malignancy","volume":"14","author":"Nicholson","year":"2002","journal-title":"Cell Signal."},{"key":"key\n\t\t\t\t20170508160334_NOP075C42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrn1847","article-title":"Notch signalling in vertebrate neural development","volume":"7","author":"Louvi","year":"2006","journal-title":"Nat Rev Neurosci."},{"key":"key\n\t\t\t\t20170508160334_NOP075C43","doi-asserted-by":"crossref","first-page":"7787","DOI":"10.1158\/0008-5472.CAN-04-1446","article-title":"Notch1 and notch2 have opposite effects on embryonal brain tumor growth","volume":"64","author":"Fan","year":"2004","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170508160334_NOP075C44","doi-asserted-by":"crossref","first-page":"e4107","DOI":"10.1371\/journal.pone.0004107","article-title":"NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas","volume":"4","author":"Benetkiewicz","year":"2009","journal-title":"PLoS ONE."},{"key":"key\n\t\t\t\t20170508160334_NOP075C45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature04727","article-title":"The DNA sequence and biological annotation of human chromosome 1","volume":"441","author":"Gregory","year":"2006","journal-title":"Nature."},{"key":"key\n\t\t\t\t20170508160334_NOP075C46","doi-asserted-by":"crossref","first-page":"e576","DOI":"10.1371\/journal.pone.0000576","article-title":"Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumors","volume":"2","author":"Boulay","year":"2007","journal-title":"PLoS ONE."},{"key":"key\n\t\t\t\t20170508160334_NOP075C47","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1349-7006.2009.01130.x","article-title":"Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma","volume":"100","author":"Lee","year":"2009","journal-title":"Cancer Sci."},{"key":"key\n\t\t\t\t20170508160334_NOP075C48","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1158\/0008-5472.CAN-08-2610","article-title":"Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas","volume":"69","author":"Sivasankaran","year":"2009","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170508160334_NOP075C49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF03195221","article-title":"Familial whole-arm translocations (1;19), (9;13), and (12;21): a review of 101 constitutional exchanges","volume":"48","author":"Vazquez-Cardenas","year":"2007","journal-title":"J Appl Genet."},{"key":"key\n\t\t\t\t20170508160334_NOP075C50","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1038\/sj.onc.1205495","article-title":"Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p","volume":"21","author":"Mukasa","year":"2002","journal-title":"Oncogene."},{"key":"key\n\t\t\t\t20170508160334_NOP075C51","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/ijc.23409","article-title":"Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss","volume":"122","author":"Riemenschneider","year":"2008","journal-title":"Int J Cancer."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/12\/7\/664\/16662888\/nop075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T17:48:56Z","timestamp":1503510536000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-lookup\/doi\/10.1093\/neuonc\/nop075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,17]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2010,2,17]]},"published-print":{"date-parts":[[2010,7]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/nop075","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2,17]]}}}